San-Miguel J, Bladé J, Shpilberg O, et al. Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti–IL-6) in multiple myeloma. Blood. 2014;123(26)

Zdroj: In Blood 14 August 2014 124(7):1201-1201
Databáze: ScienceDirect
Externí odkaz: